Periodontal Regeneration Of 1-, 2-, and 3-Walled Intrabony Defects Using Accell Connexus (registered trademark) Versus Demineralized Freeze-Dried Bone Allograft: A Randomized Parallel Arm Clinical Control Trial
Abstract
Combination therapy, in guided tissue regeneration (GTR), is often used in the treatment of intrabony defects. Particulate demineralized freeze- dried bone allograft (DFDBA) is a bone grafting materials used successfully in GTR on humans for almost 30 years. A newer form of DFDBA, Accell Connexus (Accell), has been FDA approved for use in periodontal regeneration which is the growth of new bone, cementum and periodontal ligament on a previously diseased tooth root surface. Accell Connexus contains 5-7 times more bone morphogenic proteins (BMP) than the traditional particulate DFDBA. This increase in BMP is thought to increase the potential of periodontal regeneration.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2015
- Accession Number
- AD1012682
Entities
People
- Teresita L. Alston
Organizations
- Uniformed Services University of the Health Sciences